letrozole has been researched along with Cancer of Prostate in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " To test whether the formation of E2 from T by aromatase could lead to estrogen genotoxicity and prostate carcinogenesis we then rats treated with T and 2F-E2 also with letrozole and found that it reduced prostate cancer incidence by about 50%." | 4.31 | Hormonal and genotoxic estrogen-androgen carcinogenesis in the NBL rat prostate: A role for aromatase. ( Bosland, MC; Horton, L; Schlicht, MJ; Vega, K, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Thomas, MP | 1 |
| Potter, BV | 1 |
| Bosland, MC | 1 |
| Vega, K | 1 |
| Horton, L | 1 |
| Schlicht, MJ | 1 |
| Martinez Vila, C | 1 |
| Fernández-Morales, LA | 1 |
| Oliveres, H | 1 |
| Marín, M | 1 |
| Ribera, P | 1 |
| Pardo, JC | 1 |
| Dalmau, E | 1 |
| Segui, MA | 1 |
| Masoodi, KZ | 1 |
| Ramos Garcia, R | 1 |
| Pascal, LE | 1 |
| Wang, Y | 1 |
| Ma, HM | 1 |
| O'Malley, K | 1 |
| Eisermann, K | 1 |
| Shevrin, DH | 1 |
| Nguyen, HM | 1 |
| Vessella, RL | 1 |
| Nelson, JB | 1 |
| Parikh, RA | 1 |
| Wang, Z | 1 |
| Smith, MR | 1 |
| Kaufman, D | 1 |
| George, D | 1 |
| Oh, WK | 1 |
| Kazanis, M | 1 |
| Manola, J | 1 |
| Kantoff, PW | 1 |
| Antognelli, C | 1 |
| Del Buono, C | 1 |
| Baldracchini, F | 1 |
| Talesa, V | 1 |
| Cottini, E | 1 |
| Brancadoro, C | 1 |
| Zucchi, A | 1 |
| Mearini, E | 1 |
1 trial available for letrozole and Cancer of Prostate
| Article | Year |
|---|---|
Selective aromatase inhibition for patients with androgen-independent prostate carcinoma.
Topics: Aged; Aged, 80 and over; Androgens; Antineoplastic Agents; Aromatase Inhibitors; Enzyme Inhibitors; | 2002 |
5 other studies available for letrozole and Cancer of Prostate
| Article | Year |
|---|---|
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Discovery; Endometriosi | 2015 |
Hormonal and genotoxic estrogen-androgen carcinogenesis in the NBL rat prostate: A role for aromatase.
Topics: Androgens; Animals; Aromatase; Carcinogenesis; DNA Damage; Estradiol; Estrogens; Humans; Letrozole; | 2023 |
Fulvestrant plus LHRH analogues in male with synchronous breast and prostate cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Estradiol; Fulvestrant | 2017 |
5α-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models.
Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Cell Line, Tumor; Cell Proliferation; Dutasterid | 2013 |
Alteration of glyoxalase genes expression in response to testosterone in LNCaP and PC3 human prostate cancer cells.
Topics: Adenocarcinoma; Androgens; Aromatase Inhibitors; Base Sequence; Cell Line, Tumor; Enzyme Induction; | 2007 |